HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (4- chloro- 2- fluorophenyl)- 2- hydroxybenzamide

structure in first source

Also Known As:

NDMC101

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133

Experts

1.	Chang, Deh-Ming: 1 article (08/2012)
2.	Cheng, Chia-Pi: 1 article (08/2012)
3.	Hsu, Yu-Chieh: 1 article (08/2012)
4.	Huang, Hsu-Shan: 1 article (08/2012)
5.	Sheu, Ming-Jen: 1 article (08/2012)

Related Diseases

1.	Inflammation (Inflammations) 08/01/2012 - "There results guarantee further clinical tests of NDMC101 for its therapeutic potential in the treatment of inflammation-induced bone diseases." 08/01/2012 - "Then clinical, histological, and biochemical parameters were assessed to determine the effects of N-(4-chloro-2-fluorophenyl)-2-hydroxybenzamide (NDMC101) on synovial inflammation and bone erosion by hematoxlin and eosin staining and Enzyme-linked immunosorbent assay (ELISA). "
2.	Bone Diseases (Bone Disease) 08/01/2012 - "There results guarantee further clinical tests of NDMC101 for its therapeutic potential in the treatment of inflammation-induced bone diseases."
3.	Experimental Arthritis 08/01/2012 - "A benzamide-linked small molecule NDMC101 inhibits NFATc1 and NF-κB activity: a potential osteoclastogenesis inhibitor for experimental arthritis."

Related Drugs and Biologics

1.	N- (4- chloro- 2- fluorophenyl)- 2- hydroxybenzamide
2.	Immunosorbents
3.	Eosine Yellowish-(YS) (Eosin)
4.	Enzymes
5.	benzamide